Growth hormone releasing peptide CAS 87616-84-0 GROWTH HORMONE RELEASING PEPTIDE-6

Model: MOS 33
Place of Origin: Zhejiang,China (Mainland)
Name: Growth hormone releasing peptide
CAS: 87616-84-0
Molecular Formula: C46H56N12O6
Brand: MOSINTER
Product Categories: Peptide;Peptides
Molecular Weight: 873.01
Synonyms 1: (D-TRP7,ALA8,D-PHE10)-ALPHA-MSH (6-11) AMIDE
Synonyms 2: GROWTH HORMONE RELEASING PEPTIDE-6
storage temp: -20°C

inquiry

skype basketAdd to Basket  Edit

Share |

Product Description

Payment & Shipping Terms Supply Capacity
Trade Term:FOB,CIF,DDPProduction Capacity:200KG/MONTH
Payment Terms:L/C, T/T, WUPacking:As per request of...
Min. Order:1 KilogramDelivery Date:within 7 days
Means of Transport:Ocean, Air, Land

Growth hormone releasing peptide CAS 87616-84-0 GROWTH HORMONE RELEASING PEPTIDE-6

Polypeptide; Peptides; Pharmaceutical raw materials; Peptide; Polypeptide intermediates


GHRH is released from neurosecretory nerve terminals of these arcuate neurons, and is carried by the hypothalamo-hypophyseal portal system to the anterior pituitary gland, where it stimulatesgrowth hormone (GH) secretion by stimulating the growth hormone-releasing hormone receptor. GHRH is released in a pulsatile manner, stimulating similar pulsatile release of GH. In addition, GHRH also promotes slow-wave sleep directly.Growth hormone is required for normal postnatal growth, bone growth, regulatory effects on protein, carbohydrate, and lipid metabolism.


GHRH stimulates GH production and release by binding to the GHRH Receptor (GHRHR) on cells in the anterior pituitary.


GHRH expression has been demonstrated in peripheral cells and tissues outside its main site in the hypothalamus, for example, in the pancreas, epithelial mucosa of the gastrointestinal tract and, pathologically, in tumour cells.


The GHRHR is a member of the secretin family of G protein-coupled receptors, and is located on chromosome 7. This protein is transmembranous with seven folds, and its molecular weight is approximately 44 kD.


GHRH binding to GHRHR results in increased GH production mainly by the cAMP-dependent pathway,but also by the phospholipase C pathway (IP3/DAG pathway), and other minor pathways.

The cAMP-dependent pathway is initiated by the binding of GHRH to its receptor, causing receptor conformation that activates Gs alpha subunit of the closely associated G-Protein complex on the intracellular side. This results in stimulation of membrane-bound adenylyl cyclase and increased intracellular cyclic adenosine monophosphate (cAMP). cAMP binds to and activates the regulatory subunits of protein kinase A (PKA), allowing the free catalytic subunits to translocate to the nucleus and phosphorylate the transcription factor cAMP response element-binding protein (CREB). Phosphorylated CREB, together with its coactivators, p300 and CREB-binding protein (CBP) enhances the transcription of GH by binding to CREs cAMP-response elements in the promoter region of the GH gene. It also increases transcription of the GHRHR gene, providing positive feedback.

In the phospholipase C pathway, GHRH stimulates phospholipase C (PLC) through the βγ-complex of heterotrimeric G-proteins. PLC activation produces both diacylglycerol (DAG) and inositol triphosphate (IP3), the latter leading to release of intracellular Ca2+ from the endoplasmic reticulum, increasing cytosolic Ca2+ concentration, resulting in vesicle fusion and release of secretory vesicles containing premade growth hormone.

Some Ca2+ influx is also a direct action of cAMP, which is distinct from the usual cAMP-dependent pathway of activating protein kinase A.

Activation of GHRHRs by GHRH also conveys opening of Na+ channels by phosphatidylinositol 4,5-bisphosphate, causing cell depolarization. The resultant change in the intracellular voltage opens avoltage-dependent calcium channel, resulting in vesicle fusion and release of GH.



Category: New products


«
Offline Showroom in USA
QR Code